The DOI matches its Crossref record; 55 of the 55 references it cites were found in a registry or an index.
Mechanisms of Resistance to Quinolones
Abstract
The increased use of fluoroquinolones has led to increasing resistance to these antimicrobials, with rates of resistance that vary by both organism and geographic region. Resistance to fluoroquinolones typically arises as a result of alterations in the target enzymes (DNA gyrase and topoisomerase IV) and of changes in drug entry and efflux. Mutations are selected first in the more susceptible target: DNA gyrase, in gram-negative bacteria, or topoisomerase IV, in gram-positive bacteria. Additional mutations in the next most susceptible target, as well as in genes controlling drug accumulation, augment resistance further, so that the most-resistant isolates have mutations in several genes. Resistance to quinolones can also be mediated by plasmids that produce the Qnr protein, which protects the quinolone targets from inhibition. Qnr plasmids have been found in the United States, Europe, and East Asia. Although Qnr by itself produces only low-level resistance, its presence facilitates the selection of higher-level resistance mutations, thus contributing to the alarming increase in resistance to quinolones.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
DNA gyrase, topoisomerase IV, and the 4-quinolones.
Drlica, K., & Zhao, X. (1997) · Microbiology and molecular biology reviews : MMBR · doi:10.1128/.61.3.377-392.1997 · Cited by 1,494
Quinolone resistance from a transferable plasmid
Martínez-Martínez, L., Pascual, A., & Jacoby, G. A. (1998) · The Lancet · doi:10.1016/s0140-6736(97)07322-4 · Cited by 1,100
Self-citationNeuhauser, M. M., Weinstein, R. A., Rydman, R., Danziger, L. H., Karam, G., & Quinn, J. P. (2003) · JAMA · doi:10.1001/jama.289.7.885 · Cited by 678
Magnet, S., Courvalin, P., & Lambert, T. (2001) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.45.12.3375-3380.2001 · Cited by 575
Mechanism of plasmid-mediated quinolone resistance
Tran, J. H., & Jacoby, G. A. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.082092899 · Cited by 564
Self-citationResistance to Levofloxacin and Failure of Treatment of Pneumococcal Pneumonia
Davidson, R., Cavalcanti, R., Brunton, J. L., Bast, D. J., de Azavedo, J. C. S., Kibsey, P., Fleming, C., & Low, D. E. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa012122 · Cited by 533
Regulation of chromosomally mediated multiple antibiotic resistance: the mar regulon
Alekshun, M. N., & Levy, S. B. (1997) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.41.10.2067 · Cited by 470
Plasmid-Mediated Quinolone Resistance in Clinical Isolates of Escherichia coli from Shanghai, China
Wang, M., Tran, J. H., Jacoby, G. A., Zhang, Y., Wang, F., & Hooper, D. C. (2003) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.47.7.2242-2248.2003 · Cited by 467
Self-citationCrystal structure of the breakage–reunion domain of DNA gyrase
Cabral, J. H. M., Jackson, A. P., Smith, C. V., Shikotra, N., Maxwell, A., & Liddington, R. C. (1997) · Nature · doi:10.1038/42294 · Cited by 456
Winokur, P. L., Cantón, R., Casellas, J., & Legakis, N. J. (2001) · Clinical Infectious Diseases · doi:10.1086/320182 · Cited by 440
The mutant selection window and antimicrobial resistance
Drlica, K. (2003) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkg269 · Cited by 437
Zhao, X., & Drlica, K. (2001) · Clinical Infectious Diseases · doi:10.1086/321841 · Cited by 397
Paterson, D. L., Mulazimoglu, L., Casellas, J. M., Ko, W.-C., Goossens, H., Von Gottberg, A., Mohapatra, S., Trenholme, G. M., Klugman, K. P., McCormack, J. G., et al. (2000) · Clinical Infectious Diseases · doi:10.1086/313719 · Cited by 386
Cohen, S. P., McMurry, L. M., Hooper, D. C., Wolfson, J. S., & Levy, S. B. (1989) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.33.8.1318 · Cited by 376
Hoban, D. J., Doern, G. V., Fluit, A. C., Roussel‐Delvallez, M., & Jones, R. N. (2001) · Clinical Infectious Diseases · doi:10.1086/320181 · Cited by 375
Karlowsky, J. A., Draghi, D. C., Jones, M. E., Thornsberry, C., Friedland, I. R., & Sahm, D. F. (2003) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.47.5.1681-1688.2003 · Cited by 351
Komp Lindgren, P., Karlsson, A., & Hughes, D. (2003) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.47.10.3222-3232.2003 · Cited by 350
Wang, H., Dzink-Fox, J. L., Chen, M., & Levy, S. B. (2001) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.45.5.1515-1521.2001 · Cited by 284
Interaction of the Plasmid-Encoded Quinolone Resistance Protein Qnr with Escherichia coli DNA Gyrase
Tran, J. H., Jacoby, G. A., & Hooper, D. C. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.1.118-125.2005 · Cited by 283
Self-citationWillmott, C. J., & Maxwell, A. (1993) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.37.1.126 · Cited by 252
Wang, M., Sahm, D. F., Jacoby, G. A., & Hooper, D. C. (2004) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.48.4.1295-1299.2004 · Cited by 243
Self-citationNg, E. Y., Trucksis, M., & Hooper, D. C. (1996) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.40.8.1881 · Cited by 232
Lautenbach, E., Strom, B. L., Bilker, W. B., Patel, J. B., Edelstein, P. H., & Fishman, N. O. (2001) · Clinical Infectious Diseases · doi:10.1086/322667 · Cited by 227
Oethinger, M., Kern, W. V., Jellen-Ritter, A. S., McMurry, L. M., & Levy, S. B. (2000) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.44.1.10-13.2000 · Cited by 213
Prevalence of Plasmid-Mediated Quinolone Resistance
Jacoby, G. A., Chow, N., & Waites, K. B. (2003) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.47.2.559-562.2003 · Cited by 209
Self-citationHypermutation as a Factor Contributing to the Acquisition of Antimicrobial Resistance
Eliopoulos, G. M., & Blazquez, J. (2003) · Clinical Infectious Diseases · doi:10.1086/378810 · Cited by 206
Wetzstein, H.-G., Stadler, M., Tichy, H.-V., Dalhoff, A., & Karl, W. (1999) · Applied and Environmental Microbiology · doi:10.1128/aem.65.4.1556-1563.1999 · Cited by 196
The export of the DNA replication inhibitor Microcin B17 provides immunity for the host cell.
Garrido, M. C., Herrero, M., Kolter, R., & Moreno, F. (1988) · The EMBO Journal · doi:10.1002/j.1460-2075.1988.tb03018.x · Cited by 185
Alekshun, M. N., & Levy, S. B. (1999) · Journal of Bacteriology · doi:10.1128/jb.181.15.4669-4672.1999 · Cited by 182
Multiple-dose pharmacokinetics and safety of ciprofloxacin in normal volunteers
Gonzalez, M. A., Uribe, F., Moisen, S. D., Fuster, A. P., Selen, A., Welling, P. G., & Painter, B. (1984) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.26.5.741 · Cited by 182
Barnard, F. M., & Maxwell, A. (2001) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.45.7.1994-2000.2001 · Cited by 160
A model for the mechanism of strand passage by DNA gyrase
Kampranis, S. C., Bates, A. D., & Maxwell, A. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.15.8414 · Cited by 158
Ysern, P., Clerch, B., Castańo, M., Gibert, I., Barbé, J., & Llagostera, M. (1990) · Mutagenesis · doi:10.1093/mutage/5.1.63 · Cited by 140
Characterization of fluoroquinolone-resistant mutants of escherichia coli selected in vitro
Heisig, P., & Tschorny, R. (1994) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.38.6.1284 · Cited by 132
Mechanisms of Quinolone Resistance
Hooper, D. C. (2014) · ASM Press eBooks · doi:10.1128/9781555817817.ch3 · Cited by 129
Expression of Multidrug Efflux Pump SmeDEF by Clinical Isolates of Stenotrophomonas maltophilia
Alonso, A., & Martínez, J. L. (2001) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.45.6.1879-1881.2001 · Cited by 121
Interaction of plasmid and host quinolone resistance
Martínez-Martínez, L. (2003) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkg157 · Cited by 118
Montero, C. I., Mateu, G., Rodríguez, R., & Takiff, H. E. (2001) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.45.12.3387-3392.2001 · Cited by 117
A Multidrug Resistance Regulatory Chromosomal Locus Is Widespread among Enteric Bacteria
Cohen, S., Yan, W., & Levy, S. B. (1993) · The Journal of Infectious Diseases · doi:10.1093/infdis/168.2.484 · Cited by 110
Tauch, A., Schlüter, A., Bischoff, N., Goesmann, A., Meyer, F., & Pühler, A. (2003) · Molecular Genetics and Genomics · doi:10.1007/s00438-002-0785-z · Cited by 97
Adaptive mutations produce resistance to ciprofloxacin
Riesenfeld, C. S., Everett, M., Piddock, L. J. V., & Hall, B. G. (1997) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.41.9.2059 · Cited by 87
Rodríguez-Martínez, J. M. (2003) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkg388 · Cited by 78
Quinolone Resistance Due to Reduced Target Enzyme Expression
İnce, D., & Hooper, D. C. (2003) · Journal of Bacteriology · doi:10.1128/jb.185.23.6883-6892.2003 · Cited by 74
Wenzel, R. P., Sahm, D. F., Thornsberry, C., Draghi, D. C., Jones, M. E., & Karlowsky, J. A. (2003) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.47.10.3089-3098.2003 · Cited by 59
Goldsmith, M., Sarov‐Blat, L., & Livneh, Z. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.200361997 · Cited by 54
Yagüe, G., Morris, J. E., Pan, X.-S., et al. (2002) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.46.2.413-419.2002 · Cited by 54
Quinolone Resistance Mechanisms in Pneumococci
Eliopoulos, G. M. (2004) · Clinical Infectious Diseases · doi:10.1086/382709 · Cited by 49
Dual activity of fluoroquinolones against Streptococcus pneumoniae: the facts behind the claims
Smith, H. J. (2002) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkf047 · Cited by 47
Emergence of a fluoroquinolone-resistant strain of Streptococcus pneumoniae in England
Johnson, A. P. (2003) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkg469 · Cited by 37
Lomovskaya, O., Kawai, F., & Matin, A. (1996) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.40.4.1050 · Cited by 29
Topoisomerase Targeting with and Resistance to Gemifloxacin in Staphylococcus aureus
İnce, D., Zhang, X., Silver, L. C., & Hooper, D. C. (2002) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.47.1.274-282.2003 · Cited by 29
DNA Sequence of Direct Repeats of the sull Gene of Plasmid pSa
Valentine, C. R., Heinrich, M. J., Chissoe, S. L., & Roe, B. A. (1994) · Plasmid · doi:10.1006/plas.1994.1059 · Cited by 26
Ambler, J. E., & Pinney, R. J. (1995) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/35.5.603 · Cited by 11
Quinolone Resistance and Its Clinical Relevance
Low, D. E. (2014) · ASM Press eBooks · doi:10.1128/9781555817817.ch23 · Cited by 8
Cited by
Dethlefsen, L., Huse, S., Sogin, M. L., & Relman, D. A. (2008) · PLoS Biology · doi:10.1371/journal.pbio.0060280 · Cited by 2,361
Cabello, F. C. (2006) · Environmental Microbiology · doi:10.1111/j.1462-2920.2006.01054.x · Cited by 2,329
Mechanism of Quinolone Action and Resistance
Aldred, K. J., Kerns, R. J., & Osheroff, N. (2014) · Biochemistry · doi:10.1021/bi5000564 · Cited by 1,282
Acquired Antibiotic Resistance Genes: An Overview
van Hoek, A. H. A. M., Mevius, D., Guerra, B., Mullany, P., Roberts, A. P., & Aarts, H. J. M. (2011) · Frontiers in Microbiology · doi:10.3389/fmicb.2011.00203 · Cited by 1,136
The worldwide emergence of plasmid-mediated quinolone resistance
Robicsek, A., Jacoby, G. A., & Hooper, D. C. (2006) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(06)70599-0 · Cited by 966
Self-citation
Metadata
- Authors
- Jacoby, G. A.
- Venue
- Clinical Infectious Diseases
- Publisher
- Oxford University Press (OUP)
- Published
- 2005-07-15
- Volume
- 41
- Issue
- Supplement_2
- Pages
- S120-S126
- ISSN
- 1058-4838 (ISSN-L)
- 1537-6591
- OpenAlex
- W2117834417
- Cited by
- 924
- References
- 55
- FWCI
- 11.34
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.